<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03161899</url>
  </required_header>
  <id_info>
    <org_study_id>ENST</org_study_id>
    <nct_id>NCT03161899</nct_id>
  </id_info>
  <brief_title>Evaluation of Nutritional Status in Thalassemia Major Patients in Assiut Children Hospital</brief_title>
  <official_title>Evaluation of Nutritional Status in Patients With Thalassemia Major in Assiut University Children Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thalassemia is a blood disorder passed down through families in which the body makes an&#xD;
      abnormal form of hemoglobin. There are 2 main types of thalassemia; Alpha &amp; Beta thalassemia.&#xD;
      Alpha thalassemia: occurs when a gene or genes related to the alpha globin protein are&#xD;
      missing or mutated.&#xD;
&#xD;
      Beta-thalassemia syndromes are a group of hereditary blood disorders characterized by reduced&#xD;
      or absent beta globin chain synthesis. Beta-thalassemias can be classified into:&#xD;
&#xD;
      Silent carrier: completely asymptomatic with normal hematological parameters.&#xD;
      Beta-thalassaemia minor (beta-thalassaemia trait): usually asymptomatic; diagnosis is made&#xD;
      during a work-up for mild anemia.&#xD;
&#xD;
      Beta-thalassaemia intermedia: usually a similar presentation to beta-thalassaemia major;&#xD;
      symptoms are usually less pronounced and the course is usually more insidious.&#xD;
&#xD;
      Beta-thalassaemia major : In which there is complete absence of hemoglobin A&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In Egypt beta thalassemia-major is the most common type with carrier rate of 5.3 to ≥9%and&#xD;
      1000 new cases born with beta-thalassemia major per 1.5 million live births per year.&#xD;
&#xD;
      Children born with thalassemia major are normal at birth, but develop severe hemolytic anemia&#xD;
      during the first year of life. Symptoms are those of anemia (lethargy, poor feeding,&#xD;
      pallor…etc.) failure to thrive and organomegaly. Later on they develop signs of extra&#xD;
      medullary hematopoiesis .&#xD;
&#xD;
      Optimal nutritional status is important for growth, immune function, bone health and pubertal&#xD;
      development . Various reports suggest the incidence of poor growth ranges from 25% to 75%&#xD;
      depending on thalassemia syndrome and severity of disease. This marked growth deficits raise&#xD;
      a red ﬂag for any pediatrician to evaluate nutritional status of thalassemic patients and&#xD;
      detect possible nutritional deficiencies and associated factors.&#xD;
&#xD;
      Etiology of delayed growth and malnutrition reported in thalassemic patient is multifactorial&#xD;
      including :&#xD;
&#xD;
        1. Nutritional deprivation with or without feeding difficulties arising from fatigue and&#xD;
           breathlessness&#xD;
&#xD;
        2. Increased energy expenditure secondary to hyper metabolism with or without heart failure&#xD;
&#xD;
        3. Gastrointestinal hypoxia which consequently produces anorexia and malabsorption&#xD;
&#xD;
        4. Reduction of biosynthetic activity of liver.&#xD;
&#xD;
        5. Disturbance of the endocrine function&#xD;
&#xD;
        6. Impaired synthetic hepatic function secondary to hemosiderosis and hepatitis.&#xD;
&#xD;
      The main aim of this study is to assess the nutritional status of thalassemic patient&#xD;
      attending Assiut university Children hospital and to determine the factors involved.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 15, 2018</start_date>
  <completion_date type="Actual">July 20, 2020</completion_date>
  <primary_completion_date type="Actual">May 24, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>percentage of malnutrition</measure>
    <time_frame>12 month</time_frame>
    <description>prevalence of malnutrition among thalassemic children attending assiut university children hospital</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>aetiology poor growth</measure>
    <time_frame>12 month</time_frame>
    <description>determination of the most common causes responsible for poor growth seen in thalassemic patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>decrease morbidity</measure>
    <time_frame>18 month</time_frame>
    <description>decrease morbidity by providing possible strategies for early prevention of the problem of poor growth occurring in patients with thalassemia major</description>
  </secondary_outcome>
  <enrollment type="Actual">246</enrollment>
  <condition>Thalassemia Major</condition>
  <eligibility>
    <study_pop>
      <textblock>
        all beta thalassemic patients attending the children Hematology Clinic, Children Hospital,&#xD;
        Assiut University, during the period of 1st of June 2017 till 31 th of may 2018.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients diagnosed to have thalassemia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patient with any underlaying systemic diseases other than B thalassemia major.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>asmaa refaat, MBBCH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assuit , faculty of medicine, egypt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Asmaa Refaat Abdelmonem</name>
      <address>
        <city>Assiut</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Soliman AT, El-Matary W, Fattah MM, Nasr IS, El Alaily RK, Thabet MA. The effect of high-calorie diet on nutritional parameters of children with beta-thalassaemia major. Clin Nutr. 2004 Oct;23(5):1153-8.</citation>
    <PMID>15380908</PMID>
  </reference>
  <reference>
    <citation>Fung EB. Nutritional deficiencies in patients with thalassemia. Ann N Y Acad Sci. 2010 Aug;1202:188-96. doi: 10.1111/j.1749-6632.2010.05578.x.</citation>
    <PMID>20712792</PMID>
  </reference>
  <reference>
    <citation>Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010 May 21;5:11. doi: 10.1186/1750-1172-5-11. Review.</citation>
    <PMID>20492708</PMID>
  </reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>May 19, 2017</study_first_submitted>
  <study_first_submitted_qc>May 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2017</study_first_posted>
  <last_update_submitted>July 28, 2020</last_update_submitted>
  <last_update_submitted_qc>July 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>ARAbdelmonem</investigator_full_name>
    <investigator_title>resident doctor of pediatrics</investigator_title>
  </responsible_party>
  <keyword>thalassemia - nutrition -growth</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thalassemia</mesh_term>
    <mesh_term>beta-Thalassemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

